| Name | Title | Contact Details |
|---|
Medicorp Inc is a Mont-Royal, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Baylis Medical is a world leader in the development and commercialization of high-performance cardiology devices that help physicians deliver life-changing therapies to patients.
Evolent Health supports progressive health care systems lead, build and own the path to value-based care. Headquartered in Arlington, Virginia, we are backed by: The Advisory Board Company (NASDAQ: ABCO), University of Pittsburgh Medical Center Health Plan, and TPG Growth. We integrate the people, processes and technology needed to advance value-based care delivery and innovative payment models.
At EyeCare Partners, we are on a mission to reinvent eye care by creating a network of optometry and ophthalmology practices that bring together a wealth of expertise, resources and knowledge. While our partner practices have unique cultures, we present a united front through our shared best practices, clinical research and innovative solutions to vision health. We believe everyone deserves to see life with the best vision possible. With over 300 ophthalmologists and 700 optometrists nationwide, we are committed to making high-quality eye care easy, accessible and personalized. We are elevating eye care for everyone.
Modulim is a pioneer in optical imaging solutions powered by spatial frequency domain imaging (SFDI) for noninvasive tissue and vascular assessment. Powered by SFDI, our Clarifi® Imaging System helps clinicians identify patients at-risk of complications due to microvascular dysfunction. The #ClarifiImagingSystem quantifies and maps five biomarkers of microvascular tissue oxygenation and perfusion. As a result, clinicians can quickly identify at-risk patients for earlier and more timely intervention so they may prevent complications such as diabetic foot ulcers and amputations. With its widespread adoption, our technology solutions have the potential to save limbs and lives, improve outcomes and reduce costs across the continuum of care by enabling early detection and intervention. Clarifi is affordable and easily integrated into a clinician`s practice. Clarifi imaging is supported by reimbursement (Current Procedural Terminology (CPT®) Proprietary Laboratory Analyses (PLA) code (0061U). Our proprietary technology - SFDI - was invented by Modulim`s founder and CTO David Cuccia, Ph.D., and his colleagues at UC Irvine`s Beckman Laser Institute. SFDI is a noninvasive tissue oxygen saturation technology that combines structured illumination with multiple wavelengths of light (visible and near-infrared) to allow for deeper and layer-specific assessment of tissue oxygenation and hemoglobin. This unique technology deciphers the reflection, absorbance, and scattering of light in tissue. Both David and Amaan Mazhar, Ph.D., Modulim`s VP of Research & Development, are both internationally-recognized experts in the field of medical photonics. #seebeyond